Breaking News Instant updates and real-time market news.

MDSO

Medidata

$75.66

(0.00%)

08:37
05/17/18
05/17
08:37
05/17/18
08:37

Medidata announces PhaseBio Pharma as 1,000th customer

Biotech company, PhaseBio Pharmaceuticals, has become Medidata's 1,000th customer. Medidata is the first and only eClinical company to achieve this milestone. PhaseBio intends to use the Medidata Clinical Cloud for the initial Phase I study of its newest clinical development program for treatment of an orphan cardiopulmonary disease. PhaseBio is a clinical-stage biopharmaceutical company committed to developing improved biotherapeutics for the treatment of orphan diseases, with an initial focus on cardiopulmonary indications. Like many smaller, innovative life science companies, PhaseBio chose to partner with Medidata due to its unified eClinical platform, which drives better science and business through all phases of a study

MDSO Medidata
$75.66

(0.00%)

02/08/18
PIPR
02/08/18
NO CHANGE
Target $83
PIPR
Overweight
Medidata should be bought on weakness, says Piper Jaffray
Piper Jaffray analyst Sean Wieland notes that Medidata reported a mostly in-line quarter, and tempered expectations to its $1B by 2020 goal previously stated. That said, strong bookings and backlog provide leading indicators of positive momentum for 2018 and beyond, the analyst points out, adding that the expansion of sales and marketing efforts positions Medidata well for a growing end market. Wieland reiterates an Overweight rating and $83 price target on the shares, and says he would be a buyer on today's selloff. In afternoon trading, shares of Medidata have dropped over 4% to $63.43.
02/09/18
NEED
02/09/18
NO CHANGE
Target $75
NEED
Buy
Medidata price target lowered to $75 from $90 at Needham
Needham analyst Scott Berg lowered his price target on Medidata to $75 and kept his Buy rating after the company's Q4 earnings. Berg says that while the quarter beat on revenue and bookings were more positive than in Q3, the management has backed off its 2020 $1B revenue goal, suggesting that longer term growth is slower than previously laid out.
04/20/18
JPMS
04/20/18
NO CHANGE
Target $87
JPMS
Overweight
Medidata subscription upside a 'positive signal,' says JPMorgan
JPMorgan analyst Sterling Auty views Medidata Solutions' Q1 as a step in the right direction with subscription revenue beating and growth of almost 18%. He expects further acceleration throughout the rest of the year and keeps an Overweight rating on the shares with an $87 price target. The results should be the start of the catalyst to take shares higher, Auty tells investors in a post-earnings research note titled "Subscription Upside a Positive Signal."
04/20/18
NEED
04/20/18
NO CHANGE
Target $80
NEED
Buy
Medidata price target raised to $80 from $75 at Needham
Needham analyst Scott Berg raised his price target on Medidata to $80 after "strong" Q1 earnings, saying the top-line outperformance was driven by higher subscriptions. Berg adds that the pick-up in sales and marketing expenditure was the "most important" development in the quarter, driving higher bookings activity in overseas markets. The analyst believes the added capacity supports visibility into the company's high-teen revenue growth rate for the next several years., keeping his Buy rating on Medidata.

TODAY'S FREE FLY STORIES

VLKAY

Volkswagen

$0.00

(0.00%)

, F

Ford

$9.58

0.025 (0.26%)

07:13
09/19/18
09/19
07:13
09/19/18
07:13
Hot Stocks
EU passenger car registrations up 10.5% in July, up 31.2% in August »

In July, demand for new…

VLKAY

Volkswagen

$0.00

(0.00%)

F

Ford

$9.58

0.025 (0.26%)

TM

Toyota

$125.06

2.6 (2.12%)

NSANY

Nissan

$0.00

(0.00%)

HMC

Honda

$29.69

0.725 (2.50%)

GM

General Motors

$35.11

0.09 (0.26%)

FCAU

Fiat Chrysler

$17.62

0.17 (0.97%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

, VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

07:13
09/19/18
09/19
07:13
09/19/18
07:13
Recommendations
Ligand, Viking Therapeutics analyst commentary  »

Ligand price target…

LGND

Ligand

VKTX

Viking Therapeutics

$19.47

9.07 (87.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 01

    Oct

  • 06

    Nov

ATVI

Activision Blizzard

$79.64

0.76 (0.96%)

, EA

Electronic Arts

$112.66

-0.03 (-0.03%)

07:12
09/19/18
09/19
07:12
09/19/18
07:12
Recommendations
Activision Blizzard, Electronic Arts, Take-Two, Ubisoft, Zynga analyst commentary  »

KeyBanc says buy shares…

ATVI

Activision Blizzard

$79.64

0.76 (0.96%)

EA

Electronic Arts

$112.66

-0.03 (-0.03%)

TTWO

Take-Two

$132.69

1.19 (0.90%)

UBSFY

Ubisoft

$0.00

(0.00%)

ZNGA

Zynga

$4.03

0.08 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 30

    Oct

BYSI

BeyondSpring

$25.55

-0.45 (-1.73%)

07:11
09/19/18
09/19
07:11
09/19/18
07:11
Hot Stocks
BeyondSpring granted new patent for Plinabulin by USPTO »

BeyondSpring announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPEY

Galp Energia

$0.00

(0.00%)

07:09
09/19/18
09/19
07:09
09/19/18
07:09
Downgrade
Galp Energia rating change  »

Galp Energia downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

$9.63

-0.19 (-1.93%)

07:08
09/19/18
09/19
07:08
09/19/18
07:08
Hot Stocks
Helius Medical announces partnership with Wexner Medical Center for PoNS clinic »

Helius Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMVKY

OMV AG

$0.00

(0.00%)

07:08
09/19/18
09/19
07:08
09/19/18
07:08
Upgrade
OMV AG rating change  »

OMV AG upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRU

Prudential

$100.22

1.23 (1.24%)

07:07
09/19/18
09/19
07:07
09/19/18
07:07
Hot Stocks
Prudential Financial names Ken Tanji EVP, CFO »

Prudential Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

REPYY

Repsol

$0.00

(0.00%)

07:07
09/19/18
09/19
07:07
09/19/18
07:07
Upgrade
Repsol rating change  »

Repsol upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

Store Capital

$28.24

-0.31 (-1.09%)

07:05
09/19/18
09/19
07:05
09/19/18
07:05
Initiation
Store Capital initiated  »

Store Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYGS

Hydrogenics

$6.15

0.05 (0.82%)

07:05
09/19/18
09/19
07:05
09/19/18
07:05
Hot Stocks
Hydrogenics to supply 2.5-megawatt energy storage solution for Haeolus project »

Hydrogenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TPX

Tempur Sealy

$55.12

1.16 (2.15%)

, SNBR

Sleep Number

$37.25

0.44 (1.20%)

07:03
09/19/18
09/19
07:03
09/19/18
07:03
Recommendations
Tempur Sealy, Sleep Number, Purple, Taken private analyst commentary  »

Antidumping petition…

TPX

Tempur Sealy

$55.12

1.16 (2.15%)

SNBR

Sleep Number

$37.25

0.44 (1.20%)

PRPL

Purple

$5.49

0.08 (1.48%)

MFRM

Taken private

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$38.49

2.07 (5.68%)

07:03
09/19/18
09/19
07:03
09/19/18
07:03
Hot Stocks
Unum Group selects Clearwater for investment accounting system solution »

Clearwater Analytics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$14.89

0.24 (1.64%)

07:02
09/19/18
09/19
07:02
09/19/18
07:02
Hot Stocks
Canadian Solar to supply 164 MW of modules to project in Spain »

Canadian Solar has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCRA

Vocera

$33.51

0.01 (0.03%)

07:02
09/19/18
09/19
07:02
09/19/18
07:02
Initiation
Vocera initiated  »

Vocera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

PAH

Platform Specialty Products

$12.80

0.01 (0.08%)

06:58
09/19/18
09/19
06:58
09/19/18
06:58
Downgrade
Platform Specialty Products rating change  »

Platform Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$163.70

6.97 (4.45%)

, CNI

Canadian National

$87.47

-0.195 (-0.22%)

06:56
09/19/18
09/19
06:56
09/19/18
06:56
Recommendations
Union Pacific, Canadian National, Canadian Pacific, CSX analyst commentary  »

Union Pacific shares…

UNP

Union Pacific

$163.70

6.97 (4.45%)

CNI

Canadian National

$87.47

-0.195 (-0.22%)

CP

Canadian Pacific

$206.96

1.38 (0.67%)

CSX

CSX

$74.12

0.77 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 27

    Sep

  • 16

    Oct

  • 18

    Oct

  • 06

    Nov

ROIC

Retail Opportunity

$18.87

-0.215 (-1.13%)

06:55
09/19/18
09/19
06:55
09/19/18
06:55
Initiation
Retail Opportunity initiated  »

Retail Opportunity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

AFIN

American Finance Trust

$17.52

0.53 (3.12%)

06:50
09/19/18
09/19
06:50
09/19/18
06:50
Initiation
American Finance Trust initiated  »

American Finance Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$7.55

0.97 (14.74%)

, FSLR

First Solar

$49.56

1.81 (3.79%)

06:50
09/19/18
09/19
06:50
09/19/18
06:50
Recommendations
SunPower, First Solar analyst commentary  »

JPMorgan 'warming…

SPWR

SunPower

$7.55

0.97 (14.74%)

FSLR

First Solar

$49.56

1.81 (3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$43.09

-0.41 (-0.94%)

06:50
09/19/18
09/19
06:50
09/19/18
06:50
Hot Stocks
AutoNation extends CEO Mike Jackson's contract »

AutoNation announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ZYME

Zymeworks

$14.40

0.035 (0.24%)

06:48
09/19/18
09/19
06:48
09/19/18
06:48
Hot Stocks
Zymeworks names Anthony Polverino Chief Scientific Officer »

Zymeworks has named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEDG

SolarEdge

$42.00

-0.05 (-0.12%)

06:45
09/19/18
09/19
06:45
09/19/18
06:45
Recommendations
SolarEdge analyst commentary  »

SolarEdge tariff risk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:45
09/19/18
09/19
06:45
09/19/18
06:45
General news
Breaking General news story  »

Week of 9/14 MBA Mortgage…

IBKC

Iberiabank

$83.70

-0.5 (-0.59%)

06:44
09/19/18
09/19
06:44
09/19/18
06:44
Conference/Events
Iberiabank management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.